Filing Details

Accession Number:
0001209191-12-006663
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-01 16:47:04
Reporting Period:
2012-01-31
Filing Date:
2012-02-01
Accepted Time:
2012-02-01 16:47:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333170 Nxstage Medical Inc. NXTM Electromedical & Electrotherapeutic Apparatus (3845) 043454702
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1341403 Jr E Joseph Turk C/O Nxstage Medical, Inc.
439 South Union Street, 5Th Floor
Lawrence MA 01843
President, North America No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-01-31 1,844 $8.55 91,905 No 4 M Direct
Common Stock Acquisiton 2012-01-31 978 $4.54 92,883 No 4 M Direct
Common Stock Acquisiton 2012-01-31 798 $2.11 93,681 No 4 M Direct
Common Stock Disposition 2012-01-31 5,870 $17.71 87,811 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2012-01-31 1,844 $0.00 1,844 $8.55
Common Stock Stock Option (Right to Buy) Disposition 2012-01-31 978 $0.00 978 $4.54
Common Stock Stock Option (Right to Buy) Disposition 2012-01-31 798 $0.00 798 $2.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,052 2005-09-15 2012-09-15 No 4 M Direct
15,375 2008-04-27 2015-03-26 No 4 M Direct
14,949 2009-04-05 2016-03-04 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2010, amended August 23, 2010, amended on December 16, 2010 and further amended on November 30, 2011.
  2. The stock option reported on this Form 4 was immediately exercisable as of the grant date for all shares of common stock that may be purchased under such stock option.
  3. This option was granted on March 27, 2008 and vests over four years in equal monthly installments.
  4. This option was granted on March 5, 2009 and vests over three years in equal monthly installments.